Psychedelic research transforms global mental health treatment paradigms
image: Gregor Hasler, M.D., University of Fribourg, Switzerland view more Credit: Gregor Hasler VILLARS-SUR-GLÂNE, SWITZERLAND, 2 September 2025 — In a revealing Genomic Press Interview published today in Psychedelics, Professor…
Could Trump’s second act boost these ASX psychedelic stocks?
Speculation RFK Jr’s appointment to head US Department of Health and Human Services may favourably impact medical psychedelics sector Tryptamine’s lead asset TRP-8803 is an innovative and scalable psilocin-based IV-infusion…